Bonus Biogroup Valuation
| BONS Stock | ILS 16.60 0.30 1.78% |
At this time, the firm appears to be fairly valued. Bonus Biogroup shows a prevailing Real Value of S16.27 per share. The current price of the firm is S16.6. Our model approximates the value of Bonus Biogroup from analyzing the firm fundamentals such as Shares Owned By Insiders of 49.72 %, current valuation of 169.66 M, and Return On Equity of -0.55 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Fairly Valued
Today
Please note that Bonus Biogroup's price fluctuation is somewhat reliable at this time. Calculation of the real value of Bonus Biogroup is based on @@bw1EO months time horizon. Increasing Bonus Biogroup's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Bonus Biogroup is useful when determining the fair value of the Bonus stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Bonus Biogroup. Since Bonus Biogroup is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bonus Stock. However, Bonus Biogroup's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.6 | Real 16.27 | Hype 16.6 | Naive 17.42 |
The real value of Bonus Stock, also known as its intrinsic value, is the underlying worth of Bonus Biogroup Company, which is reflected in its stock price. It is based on Bonus Biogroup's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Bonus Biogroup's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bonus Biogroup's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bonus Biogroup helps investors to forecast how Bonus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bonus Biogroup more accurately as focusing exclusively on Bonus Biogroup's fundamentals will not take into account other important factors: Bonus Biogroup Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Bonus Biogroup's current stock value. Our valuation model uses many indicators to compare Bonus Biogroup value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bonus Biogroup competition to find correlations between indicators driving Bonus Biogroup's intrinsic value. More Info.Bonus Biogroup is number one stock in price to book category among related companies. It is number one stock in beta category among related companies totaling about 0.41 of Beta per Price To Book. The ratio of Price To Book to Beta for Bonus Biogroup is roughly 2.41 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bonus Biogroup by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bonus Biogroup's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bonus Biogroup's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bonus Biogroup's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bonus Biogroup and how it compares across the competition.
About Bonus Biogroup Valuation
The stock valuation mechanism determines the current worth of Bonus Biogroup on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Bonus Biogroup. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Bonus Biogroup based exclusively on its fundamental and basic technical indicators. By analyzing Bonus Biogroup's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Bonus Biogroup's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bonus Biogroup. We calculate exposure to Bonus Biogroup's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bonus Biogroup's related companies.Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. Bonus BioGroup Ltd., formerly known as Oceana Advanced Industries Ltd., was founded in 1981 and is based in Haifa, Israel. BONUS BIOGROUP is traded on Tel Aviv Stock Exchange in Israel.
8 Steps to conduct Bonus Biogroup's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bonus Biogroup's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bonus Biogroup's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bonus Biogroup's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bonus Biogroup's revenue streams: Identify Bonus Biogroup's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bonus Biogroup's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bonus Biogroup's growth potential: Evaluate Bonus Biogroup's management, business model, and growth potential.
- Determine Bonus Biogroup's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bonus Biogroup's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bonus Biogroup. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Bonus Stock analysis
When running Bonus Biogroup's price analysis, check to measure Bonus Biogroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonus Biogroup is operating at the current time. Most of Bonus Biogroup's value examination focuses on studying past and present price action to predict the probability of Bonus Biogroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonus Biogroup's price. Additionally, you may evaluate how the addition of Bonus Biogroup to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |